DK134489A - Forbindelser, der inhiberer biosyntesen af lipoxygenaseafledte nedbrydningsprodukter af arachidonsyre - Google Patents

Forbindelser, der inhiberer biosyntesen af lipoxygenaseafledte nedbrydningsprodukter af arachidonsyre

Info

Publication number
DK134489A
DK134489A DK134489A DK134489A DK134489A DK 134489 A DK134489 A DK 134489A DK 134489 A DK134489 A DK 134489A DK 134489 A DK134489 A DK 134489A DK 134489 A DK134489 A DK 134489A
Authority
DK
Denmark
Prior art keywords
degraduate
biosynthesis
products
arachidonic acid
compounds inhibiting
Prior art date
Application number
DK134489A
Other languages
English (en)
Other versions
DK134489D0 (da
Inventor
Edward S Lazer
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of DK134489D0 publication Critical patent/DK134489D0/da
Publication of DK134489A publication Critical patent/DK134489A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/205—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing only six-membered aromatic rings as cyclic parts with unsaturation outside the rings
    • C07C39/21—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing only six-membered aromatic rings as cyclic parts with unsaturation outside the rings with at least one hydroxy group on a non-condensed ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/24—Halogenated derivatives
    • C07C39/373—Halogenated derivatives with all hydroxy groups on non-condensed rings and with unsaturation outside the aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/562—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with nitrogen as the only hetero atom
    • C07C45/565—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with nitrogen as the only hetero atom by reaction with hexamethylene-tetramine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyridine Compounds (AREA)
DK134489A 1988-03-21 1989-03-20 Forbindelser, der inhiberer biosyntesen af lipoxygenaseafledte nedbrydningsprodukter af arachidonsyre DK134489A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17051288A 1988-03-21 1988-03-21

Publications (2)

Publication Number Publication Date
DK134489D0 DK134489D0 (da) 1989-03-20
DK134489A true DK134489A (da) 1989-09-22

Family

ID=22620151

Family Applications (1)

Application Number Title Priority Date Filing Date
DK134489A DK134489A (da) 1988-03-21 1989-03-20 Forbindelser, der inhiberer biosyntesen af lipoxygenaseafledte nedbrydningsprodukter af arachidonsyre

Country Status (16)

Country Link
EP (1) EP0334119B1 (da)
JP (1) JPH024729A (da)
KR (1) KR890014514A (da)
AU (1) AU628324B2 (da)
DD (1) DD283602A5 (da)
DE (1) DE68907095T2 (da)
DK (1) DK134489A (da)
ES (1) ES2056983T3 (da)
FI (1) FI891295L (da)
HU (2) HU9201174D0 (da)
IL (1) IL89666A0 (da)
NO (1) NO169648C (da)
NZ (1) NZ228410A (da)
PH (1) PH26928A (da)
PT (1) PT90066B (da)
ZA (1) ZA892086B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993016067A1 (en) * 1992-02-11 1993-08-19 Allergan, Inc. Heteroaryl substituted phenylethenyl compounds having retinoid-like biological activity
EP0595546B1 (en) * 1992-10-28 1996-03-20 Shionogi & Co., Ltd. Benzylidene derivatives
ES2087019B1 (es) * 1994-02-08 1997-03-16 Bobel246 S L Uso de derivados de fenoles 2,4-disubstituidos como inhibidores de la 5-lipoxigenasa.
TW544448B (en) * 1997-07-11 2003-08-01 Novartis Ag Pyridine derivatives
NZ510743A (en) * 1998-10-02 2003-10-31 Novartis Ag mGluR5 antagonists for the treatment of pain and anxiety
US6376524B1 (en) * 2000-06-21 2002-04-23 Sunesis Pharmaceuticals, Inc. Triphenyl compounds as interleukin-4 antagonists
US20040102517A1 (en) 2001-01-18 2004-05-27 Genhui Chen Novel1,2-diphenylethene derivatives for treatment of immune diseases
MXPA04000695A (es) 2001-07-23 2005-08-26 Galileo Pharmaceuticals Inc Compuestos citoprotectores, formulaciones farmaceuticas y cosmeticas y metodos.
ES2530579T3 (es) 2003-12-23 2015-03-03 Abraxis Bioscience Llc Análogos de propofol, procedimiento para su preparación, y procedimientos de uso
WO2006078941A2 (en) * 2005-01-20 2006-07-27 Sirtris Pharmaceuticals, Inc. Novel sirtuin activating compounds and methods of use thereof
JP6912664B2 (ja) 2017-11-10 2021-08-04 ダーマヴァント サイエンシーズ ゲーエムベーハー タピナロフを調製するためのプロセス

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3188315A (en) * 1960-05-18 1965-06-08 Schering Corp Novel compounds for lowering blood cholesterol levels
FR1390978A (fr) * 1963-11-20 1965-03-05 Ind Chimique Sa Procédé de préparation de l'alpha-(thiényl-2) 4-hydroxystilbène et de quelques dérivés et produits obtenus
US4758586A (en) * 1985-02-01 1988-07-19 Usv Pharmaceutical Corp. Indolyl compounds and hyposensitivity use thereof
DE3602473A1 (de) * 1986-01-28 1987-07-30 Basf Ag Vinylphenolderivate, ihre herstellung und verwendung
US4743606A (en) * 1986-03-25 1988-05-10 Boehringer Ingelheim Pharmaceuticals, Inc. 3-[2-(3',5'-di-t-butyl-4'-hydroxyphenyl)ethenyl]pyridine having anti-inflammatory and anti-arthritic properties
US4851423A (en) * 1986-12-10 1989-07-25 Schering Corporation Pharmaceutically active compounds
CA1338645C (en) * 1987-01-06 1996-10-15 George R. Pettit Isolation, structural elucidation and synthesis of novel antineoplastic substances denominated "combretastatins"

Also Published As

Publication number Publication date
DD283602A5 (de) 1990-10-17
JPH024729A (ja) 1990-01-09
DK134489D0 (da) 1989-03-20
IL89666A0 (en) 1989-09-28
FI891295A7 (fi) 1989-09-22
ES2056983T3 (es) 1994-10-16
HU207858B (en) 1993-06-28
PT90066B (pt) 1994-05-31
HU9201174D0 (en) 1992-07-28
AU3151489A (en) 1989-09-21
DE68907095T2 (de) 1994-01-05
AU628324B2 (en) 1992-09-17
NZ228410A (en) 1993-08-26
KR890014514A (ko) 1989-10-24
FI891295A0 (fi) 1989-03-20
PT90066A (pt) 1989-11-10
NO891114D0 (no) 1989-03-15
EP0334119B1 (en) 1993-06-16
EP0334119A1 (en) 1989-09-27
NO169648B (no) 1992-04-13
FI891295L (fi) 1989-09-22
DE68907095D1 (de) 1993-07-22
NO891114L (no) 1989-09-22
HUT50093A (en) 1989-12-28
PH26928A (en) 1992-12-03
NO169648C (no) 1992-07-22
ZA892086B (en) 1990-11-28

Similar Documents

Publication Publication Date Title
DK536288D0 (da) 2-anilino-pyrimidin-derivater
DK285686A (da) Heterocykliske forbindelser som fungicider
NO862861L (no) Fremgangsmaate for fremstilling av distamycinderivater.
FI940573L (fi) Geneseriinin johdannaiset koliiniestraasin inhibiittoreina
DK134489D0 (da) Forbindelser, der inhiberer biosyntesen af lipoxygenaseafledte nedbrydningsprodukter af arachidonsyre
FI924355A7 (fi) Substituoituja imidatsolyylipropeenihappojohdannaisia
MX9205003A (es) Derivados novedosos de benzopirano.
FI880371A0 (fi) Foerfarande foer framstaellning av 4-aryl-n-/2-(dialkylamino- och heterocykliska -amino) alkyl/-1-piperazin-karboxaminer.
FI950842A7 (fi) Enkefalinaasin inhibiittoreina käyttökelpoisia uusia 2-substituoituja trisyklisiä indaani-2-merkaptoasetyyliamidijohdannaisia
FI931204A7 (fi) Uusia aminobentsosultaamijohdannaisia lipo-oksigenaasin estäjinä
DK121786A (da) Fremgangsmaade til fremstilling af et kornformigt produkt, der indeholder natriumtriphosphat
MX9204370A (es) Derivados de pirazol.
DE3672254D1 (de) Hemmung des wegs der 5-lipoxydase.
DK560989A (da) Anvendelse af ethylendiamintetraeddikesyre til fremstilling af laegemidler
MX9201931A (es) Nuevos derivados de tiazol.
DE69221897D1 (de) Herstellung von 2-(pyridyl)ethyl substituierte phosphor-verbindungen
FI823874L (fi) Markering av kompoundprodukter, saerskilt med glastraodar armerade gipsprodukter
AU548971B2 (en) Melamine derivatives as prevulcanization inhibitors
DE3676668D1 (de) Herbizide derivate von substituierten benzoylhydraziniumverbindungen.
DK211589A (da) Enhed til emballering af foedevarer
NO901422L (no) Fremgangsmaate for fremstilling av alfa-glucosidase-inhibitorer.
DK289382A (da) Fremgangsmaade til fremstilling af hidtil ukendte derivater af benzoylphenylpiperidin
DE3673732D1 (de) Propionamidin-derivate.
DE3581042D1 (de) Fungizide substituierte 2-aminopropensaeure-derivate.
FI953518A0 (fi) Uudet substituoidut tiosemikarbatsonijohdannaiset

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment